DoW Toxic Exposures Clinical Trial Award
Grant Opportunity Analysis
The Department of the Army’s USAMRAA is funding the FY26 Toxic Exposures Research Program Clinical Trial Award to support clinical trials on prevention, treatment, or management of health effects linked to military-related toxic exposures. The award covers projects ranging from small proof-of-concept studies to larger efficacy and pragmatic trials, with the goal of advancing promising interventions and knowledge products into clinical use. It encourages interdisciplinary collaboration through a Partnering Principal Investigator option, and applications must include a project narrative, detailed study design, statistical plan, regulatory strategy, and post-award transition plan; preclinical and animal research are not supported. The program offers $4.5 million for one clinical trial over four years, with a pre-application due August 19, 2026 and a full application due November 19, 2026.